Acquisitions - Additional Information (Detail)		3 Months Ended		12 Months Ended
	Jul. 02, 2021 USD ($) Installment	Sep. 30, 2027 USD ($)	Sep. 30, 2024 USD ($)	Sep. 30, 2023 USD ($)	Sep. 30, 2022 USD ($)	Sep. 30, 2021 USD ($)
Business Acquisition [Line Items]
Measurement period adjustment					$ 277,000
Revenue				$ 132,584,000	99,951,000	$ 105,136,000
Net income (loss)				$ (1,536,000)	(27,274,000)	4,237,000
Vetex Medical Limited [Member]
Business Acquisition [Line Items]
Cash paid	$ 39,900,000
Deferred consideration payment, number of installment | Installment	2
Contingency period ending year	2027
Measurement period adjustment					$ 300,000
Revenue						0
Net income (loss)						(900,000)
Acquisition transaction, integration and other costs						$ 1,000,000.0
Vetex Medical Limited [Member] | Forecast [Member]
Business Acquisition [Line Items]
Deferred consideration, contractual value		$ 1,800,000	$ 1,800,000
Vetex Medical Limited [Member] | Developed Technology [Member]
Business Acquisition [Line Items]
Acquired intangible assets amortized on straight-line basis, estimated useful life				12 years
Vetex Medical Limited [Member] | Secured Revolving Credit Facility [Member]
Business Acquisition [Line Items]
Business combination, consideration transferred, liabilities incurred	$ 10,000,000.0